No abstract available
Publication types
-
Clinical Trial, Phase II
-
Letter
-
Multicenter Study
MeSH terms
-
Antineoplastic Agents / therapeutic use*
-
Boronic Acids / therapeutic use*
-
Bortezomib
-
Humans
-
Primary Myelofibrosis / drug therapy*
-
Pyrazines / therapeutic use*
Substances
-
Antineoplastic Agents
-
Boronic Acids
-
Pyrazines
-
Bortezomib